REVERSE PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHIC  METHOD FOR THE ANALYSIS OF GLIPIZIDE IN PHARMACEUTICAL DOSAGE FORMS by Sheikh Rahila & Karigar Asif
Karigar A et al / IJRAP 2010, 1 (2) 455-458 
International Journal of Research in Ayurveda & Pharmacy, 1(2), Nov-Dec 2010  455-458   
 
Research Article    Available online through      
  www.ijrap.net 
 
REVERSE PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHIC 
 METHOD FOR THE ANALYSIS OF GLIPIZIDE IN  
PHARMACEUTICAL DOSAGE FORMS  
 
Sheikh Rahila
1, Karigar Asif*
2 
1Institute of Pharmaceutical Education and Research,   Borgaon (Meghe), Wardha, India 
2Maratha Mandal College of Pharmacy, Belgaum, Karnataka, India 
 
Received: 08-10-2010; Revised: 13-11-2010; Accepted: 25-11-2010 
 
ABSTRACT 
A rapid and sensitive reverse phase high performance liquid chromatographic methods depicted for the 
qualitative  and  quantitative  assay  of  glipizide  in  pharmaceutical  dosage  forms.  Glipizide  was 
chromatographed  on  reverse  phase  C18  column  with  mobile  phase  consisting  of  0.05  M  Potassium 
Dihydrogen Orthophosphate: Methanol [15: 85 %v/v, pH 7.0 ± 0.05, adjusted with 1% Triethylamine]. 
The mobile phase was pumped at a flow rate 1 mL/min. Quantification was achieved by monitoring the 
ultraviolet absorbance at 225 ηm. The average retention time for Glipizide was found to be 3.21 ± 0.07. 
With this method, linearity was observed in the range of 10 – 2000 ηg/ml. The LOD and LOQ were found 
to be    5 ηg/ml and 15 ηg/ml respectively. The method was applicable for the analysis of drug in tablet 
formulation. The results of analysis were validated statistically. 
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INTRODUCTION 
Glipizide
 1-2 {N-[2-[4 (cyclohexylcarbamoylsulfamoyl) phenyl] ethyl methyl-pyrazine-2-carboxamide}
   is 
sulfonylurea urea oral hypoglycemic drugs used in Type II Diabetes Mellitus. It produces its action by 
blocking potassium channels in the beta cells of the islets of langerhans. A few bioassays for analysis of 
glipizide in plasma or serum have been reported
  3
. The determination of glipizide in plasma has been 
performed by radioimmunoassay technique
  3. However, the selectivity of these methods has not been 
verified.  Gas  Chromatography  (GC)  has  also  been  used  for  determination  of  glipizide  in  plasma
  4. 
However,  GC  requires  a  time  consuming  derivatization  step  to  give  volatile  and  thermally  stable 
derivatives. One of the GC techniques
 4 also lack selectivity, since structurally similar sulphonylurea (e.g. 
Glibenclamide) may form identical derivatives.  Wahlin-Boll and Melander
 5 described a sensitive high 
performance liquid chromatographic (HPLC) technique for the measurement of glipizide concentrations 
in human serum. The method is limited by a relatively long elution time (25- 30 min) for each sample. 
Hakan  Emilsson  also  described  high  performance  liquid  chromatographic  (HPLC)  technique  for 
determination of glipizide in human plasma and urine
 6, the method is again limited by long elution time 
(10.5  min).  Glipizide  in  combination  with  other  drugs  has  been  determined  by  several  techniques 
including Liquid Chromatography- Tendem Mass Spectrometry
 7-8. 
The HPLC methods using the most commonly available columns and detectors like UV are preferred. 
The present study describes the determination of glipizide in pharmaceutical dosage forms by using RP-
C18 column with UV detectors. Owing to the widespread use of HPLC in routine analysis, it is important 
that well validated HPLC methods are to be developed for estimating glipizide. The aim of this study is 
development of simple, precise, rapid, accurate and economical reverse phase HPLC  method for the 
estimation of glipizide in different pharmaceutical dosage forms. 
 
MATERIALS AND METHODS 
Instrument 
Chromatographic separation was performed on a Jasco PU 1580 intelligent pump, variable wavelength 
UV/VIS detector (Jasco UV 1575),  precision loop injector (Rheodyne 20µl), Borwin Software (version 
1.21.60). Column C18 Intersil (250 X 4.6 i.d., particle size 10µm) was used for the separation.  
 
Materials 
All the chemicals and solvents used during project work were of analytical grade. Standard gift samples 
of Glipizide were procured from Aristo Pharmaceutical, Pvt, Ltd. Raisen (M.P), India. 
 
Preparation of Mobile Phase 
The mobile phase used was a mixture of 0.05M Potassium Dihydrogen orthophosphate: Methanol [15: 85 
%v/v, pH 7.0 ± 0.05, pH adjusted with 1% Triethylamine].  It was filtered through Whatman filter paper 
No. 42. The elution was carried out isocratically at the flow rate of 1.0 mL/min. Detection was carried out 
at 225 ηm.  
 
  Preparation of Standard Solution 
Standard  stock  solutions  of  glipizide  1  mg  mL
-1  were  prepared  in  methanol.  Working  solutions  of 
appropriate concentrations were made by dilution of the stock solution with mobile phase. The standard 
calibration curve was prepared contained 10-2000 ηg mL
-1 glipizide. Twenty micro liters of each solution 
was injected into the HPLC system to obtain the chromatogram. From these chromatograms, the areas 
under the peaks of the drug were noted. The regression of the drug concentration over these ratios was 
computed. The method follows the regression equation y= 69.766x with coefficient of correlation R
2 = 
0.9992. The  recovery  studies  were  carried  out by  adding  known  amount  of  glipizide  to  preanalysed 
samples and then analyzing them by the proposed HPLC method.  
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Preparation of Sample Solutions 
Twenty tablets (GLYNASE
®, USV Limited, Mumbai, India.) containing 5 mg of Glipizide was taken, 
average weight was determined. Weight equivalent to 5 mg of Glipizide was taken in 100 mL volumetric 
flask and 40 mL of methanol was added and sonicated for 30 min, finally volume was made up to the 
mark  with  methanol.  The  extracts  were  filtered  through  Whatman  filter  paper  No.  42  and  required 
dilutions were made with mobile phase and mixed well. Each of these solutions (20 µL) was then injected 
5 times into the column. The mean peak area of the drug of 5 such determination was calculated and the 
drug content in the tablets was quantified using the regression equation obtained for pure sample.  
 
Assay Method 
With  the  optimized  chromatographic  conditions,  a  steady  baseline  was  recorded, the  mixed  standard 
solutions were injected and the chromatogram was recorded. The retention time of Glipizide was found to 
be 3.21 ± 0.07 min. This procedure was repeated for the sample solution obtained from the formulation. 
The response factor (peak area) of the standard solution and sample solution was recorded. The analyte 
concentration of the drugs was quantified using the regression equation obtained for the pure sample.  
To study the accuracy, reproducibility and precision of the above proposed methods, recovery studies 
were carried out by addition of standard drug to pre-analyzed sample.  
 
RESULTS 
Results of recovery studies were found to be satisfactory and reported in Table 1. The low coefficient of 
variation and recovery close to 100% indicating the reproducibility and accuracy of the assay of glipizide 
in tablets. 
 
DISCUSSION 
The drug content in the tablets was quantified using the proposed analytical method. The mean amount of 
glipizide in tablet dosage form is shown in Table 1. The absence of additional peaks in the chromatogram 
indicates non-interference of the common excipients used in the tablets. The tablet were found to contain 
99.77- 99.88% of the labeled amount of the drug. 
 
CONCLUSION 
With HPLC assay method, the response factor (peak area) of the standard solution and sample solution 
was  recorded.  The  analyte  concentration  of  the  drugs  was  quantified  using  the  regression  equation 
obtained for the pure sample. Each of the samples was injected 5 times and almost same retention times 
were obtained in all cases. When glipizide solutions analyzed by proposed method for finding out inter- 
and intra-day variations, a low coefficient of variation was observed (0.0709). This shows that the present 
HPLC method is highly precise. A recovery of 99.96 % of glipizide from the preanalysed samples shows 
that the present method is highly accurate. 
It can be concluded that the proposed HPLC method is sensitive and reproducible for the analysis of 
glipizide in pharmaceutical dosage forms within a short analysis time. 
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Table 1: Recovery Study Data of Tablet Formulation 
   
Drug 
Assay results  Amount 
added 
μg/mL 
Amount 
recovered 
μg/mL 
(n=5) 
Recovery 
(%) 
Average 
recovery (%) 
Actual  
concentratio
n (mg) 
Concentration 
found (%) 
(n=5) 
 
Glipizide 
 
5.0 
99.86  0.4  0.398  100.01   
99.96  99.77  0.5  0.499  99.98 
99.88  0.6  0.597  99.89 
*Mean of three determinations  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Typical chromatograms of Glipizide (Rt 3.21 ± 0.07) 
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